Advertisement

Topics

Sanofi 2Q Sales Growth Boosted by Specialty Care, Vaccines, and Emerging Markets

10:09 EDT 31 Jul 2017 | PharmPro

The company's second-quarter and first-half 2017 accounts reflect the acquisition of the former Boehringer Ingelheim Consumer Healthcare business and the disposal of the Animal Health business completed on January 1, 2017.
Contributed Author: 
Sanofi
Topics: 

Original Article: Sanofi 2Q Sales Growth Boosted by Specialty Care, Vaccines, and Emerging Markets

NEXT ARTICLE

More From BioPortfolio on "Sanofi 2Q Sales Growth Boosted by Specialty Care, Vaccines, and Emerging Markets"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...